The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Opioid Analgesics Suppress Male Gonadal Function, but Opioid Use in Men and Women Does Not Correlate with Symptoms of Sexual Dysfunction
Open accessAbstract
BACKGROUND: Opioid analgesia impairs gonadal function in men and women, but the correlation with symptoms and hormonal measurements of hypogonadism is not well established. OBJECTIVE: To determine the frequency of impaired gonadal function in men and women using opioids for chronic pain, and to determine the correlation of symptoms with hormonal measurements of gonadal function. METHODS: A prospective study of patients attending a multidisciplinary pain clinic was conducted. A total of 65 women (47 opioid users and 18 nonopioid analgesic controls) and 32 men (26 opioid users and six controls) were enrolled. Histories of sexual dysfunction and hormonal testing (men: total testosterone [TT], free testosterone [FT], prolactin and luteinizing hormone; women: FT, TT, prolactin, dehydroepiandrosterone sulphate, sex hormone‐binding globulin, progesterone, luteinizing hormone and follicle‐stimulating hormone, and estradiol) were obtained. RESULTS: In men, a low FT level was more common in opioid users (20/26; P=0.04). In men with abnormal hormone levels, there was no difference in the frequency of sexual dysfunction compared with men with normal hormone levels, and no difference in the frequency of opioid versus nonopioid use. In women, opioid users had lower FT levels (P=0.02). Low dehydroepiandrosterone sulphate was more frequent in women on opioids (P=0.03) in the menopausal group only (P=0.046). Premenopausal women taking opioids more frequently had a low TT level (P=0.03). The frequency of female sexual dysfunction was the same in opioid users (32/47) and controls (13/18; P=0.75), and also did not relate to any hormone abnormality. DISCUSSION: Men taking opioids had lower FT and higher prolactin levels, and women taking opioids had lower FT levels. Frequency of sexual dysfunction did not correlate with hormone levels in either men or women taking opioids. CONCLUSION: Opioids frequently cause low FT levels in men, but there is no relationship between abnormal hormone levels and symptoms of sexual dysfunction. Therefore, all men should be screened for low FT levels. Women on opioids had lower FT levels, but this did not correlate with sexual dysfunction symptoms. Therefore, measurements of FT or other hormones were not considered to be useful in women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, hyperprolactinemia has not been confirmed in other studies involving noncancer pain patients on intrathecal or oral opioids (74, 136, 148), although in one of them, PRL was higher (but still within normal range) in men in the opioidtreated group, as compared with the controls (148).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [148]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The effects of opioids and opioid analogs on animal and human endocrine systems
Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0009 · Cited by 564
Trends in Medical Use and Abuse of Opioid Analgesics
Joranson, D. E. (2000) · JAMA · doi:10.1001/jama.283.13.1710 · Cited by 504
Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial
Buster, J. E., Kingsberg, S. A., Aguirre, O., Brown, C., Breaux, J. G., Buch, A., Rodenberg, C. A., Wekselman, K., & Casson, P. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000158103.27672.0d · Cited by 433
Hypogonadism in men consuming sustained-action oral opioids
Daniell, H. W. (2002) · The Journal of Pain · doi:10.1054/jpai.2002.126790 · Cited by 401
Daniell, H. W. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.08.005 · Cited by 263 · cited 2×
“Although most studies demonstrate suppression of testosterone in men (4,11,12), sexual dysfunction in men and women has been inconsistently studied (11,13,14).”
BackgroundResultDaniell, H. (2006) · Journal of Pain · doi:10.1016/j.jpain.2006.04.011 · Cited by 144
Decreased serum testosterone concentration in male heroin and methadone addicts
Azizi, F., Vagenakis, A. G., Longcope, C., Ingbar, S. H., & Braverman, L. E. (1973) · Steroids · doi:10.1016/0039-128x(73)90002-0 · Cited by 130
Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women
Fraser, L.-A., Morrison, D., Morley-Forster, P., Paul, T., Tokmakejian, S., Larry Nicholson, R., Bureau, Y., Friedman, T., & Uum, S. H. M. V. (2008) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2008-1076715 · Cited by 112 · cited 1×
“Pain Res Manage Vol 16 No 5 September/October 2011 312 fatigue, hot flashes, mild anemia, osteoporosis and sarcopenia in men (10), and amenorrhea, oligomenorrhea, sexual dysfunction, fatigue, depression and osteoporosis in women.”
BackgroundHypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy
Rajagopal, A., Vassilopoulou‐Sellin, R., Palmer, J. L., Kaur, G., & Bruera, E. D. (2003) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(03)00331-2 · Cited by 91
Opioid-induced suppression of rat testicular function.
Adams, M. L., Sewing, B. N., Forman, J. B., Meyer, E. R., & Cicero, T. J. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38343-6 · Cited by 87
Guay, A., Munarriz, R. M., Jacobson, J., Talakoub, L., Traish, A. M., Quirk, F. H., Goldstein, I., & Spark, R. (2004) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901178 · Cited by 70
Guay, A., Jacobson, J., Munarriz, R. M., Traish, A. M., Talakoub, L., Quirk, F. H., Goldstein, I., & Spark, R. (2004) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901176 · Cited by 62
Chronic Pain and Opiates: Balancing Pain Control and Risks in Long-Term Opioid Treatment
Gallagher, R. M., & Rosenthal, L. J. (2008) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2007.12.003 · Cited by 55
The Impact of Sampling and Measurement on the Prevalence of Self‐Reported Pain in Canada
Kerkhof, E. G. V. D., Hopman, W. M., Towheed, T., Anastassiades, T., & Goldstein, D. H. (2003) · Pain Research and Management · doi:10.1155/2003/493047 · Cited by 48
Effects of heroin on thyroid function, cortisol and testosterone level in addicts.
Rasheed, A., & Tareen, I. A. (1995) · PubMed · Cited by 44
Enhanced prolactin levels in opium smokers
Moshtaghi‐Kashanian, G., Esmaeeli, F., & Dabiri, S. (2005) · Addiction Biology · doi:10.1080/13556210500351263 · Cited by 34 · cited 1×
“Fentanyl patches of 25 μg/h were considered to be equivalent to 90 mg of daily oral morphine (15).”
BackgroundGiri, M., & Kaufman, J. (1994) · Endocrinology · doi:10.1210/endo.135.5.7956937 · Cited by 25
Giri, M. (1994) · Endocrinology · doi:10.1210/en.135.5.2137 · Cited by 9
Cited by
Opioids and their endocrine effects: a systematic review and meta-analysis
de Vries, F., Bruin, M., Lobatto, D. J., Dekkers, O. M., Schoones, J. W., van Furth, W. R., Pereira, A. M., Karavitaki, N., Biermasz, N. R., & Zamanipoor Najafabadi, A. H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz022 · Cited by 139
Yeap, B. B., Grossmann, M., McLachlan, R. I., Handelsman, D. J., Wittert, G. A., Conway, A. J., Stuckey, B. G., Lording, D. W., Allan, C. A., Zajac, J. D., et al. (2016) · Medical Journal of Australia · doi:10.5694/mja16.00393 · Cited by 135
Sexual Dysfunction in Patients with Alcohol and Opioid Dependence
Grover, S., Mattoo, S. K., Pendharkar, S. S., & Kandappan, V. (2014) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.140699 · Cited by 140
“[79] A major limitation of these data has been the lack of standard instruments to assess SD; only four recent studies using International Index of Erectile Function (IIEF), of which two used full form of IIEF to assess SD.”
BackgroundInfluentialMECHANISMS OF ENDOCRINOLOGY: endocrinology of opioids
Fountas, A., Chai, S. T., Kourkouti, C., & Karavitaki, N. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0270 · Cited by 60
Tramadol Abuse and Sexual Function
Abdel‐Hamid, I. A., Andersson, K., Waldinger, M. D., & Anis, T. H. (2016) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2015.10.014 · Cited by 57
Metadata
- Authors
- Wong, D., Gray, D., Simmonds, M., Rashiq, S., Sobolev, I., & Morrish, D. W.
- Affiliations
- University of Alberta (CA)
- Corresponding author
- Morrish, Donald W
- Venue
- Pain Research and Management
- Publisher
- Wiley
- Published
- 2011-01
- Volume
- 16
- Issue
- 5
- Pages
- 311-316
- ISSN
- 1203-6765 (ISSN-L)
- 1918-1523
- PMC
- PMC3206779
- OpenAlex
- W978144381
- Semantic Scholar
- d5c54e00e38695028bf9e4f7814b80cdd3fd5c52
- Cited by
- 32
- References
- 17
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 6 · 2014: 2 · 2013: 1 · 2012: 1
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pain Research and Management (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Alberta Council of Professionals for Sexual Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Keywords
- opioid analgesics, gonadal function, hypogonadism, sexual dysfunction, free testosterone, chronic pain, prolactin, dehydroepiandrosterone sulfate, sex hormone-binding globulin, luteinizing hormone, estradiol, menopause, women with chronic pain, multidisciplinary pain clinic, non-opioid analgesics
- MeSH terms
- Adult, Aged, Aged, 80 and over, Analgesics, Opioid, Female, Humans, Male, Middle Aged, Opioid-Related Disorders, Pituitary Hormones, Prolactin, Prospective Studies, Sex Factors, Statistics as Topic, Sexual Dysfunctions, Psychological, Gonadal Hormones, Chronic Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.